Managing symptoms of multiple sclerosis

Neurologic Clinics

Volumn 23, Issue 1, 2005, Pages 177-187

  Schapiro, Randall T ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Minneapolis Clinic of Neurology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; AMITRIPTYLINE; AMPHETAMINE; ANTIDEPRESSANT AGENT; BACLOFEN; BOTULINUM TOXIN; BUSPIRONE; CANNABINOID; CARBAMAZEPINE; CLONAZEPAM; DESMOPRESSIN; DIAZEPAM; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; FLUOXETINE; GABAPENTIN; IMIPRAMINE; METHYLPHENIDATE; MODAFINIL; OXYBUTYNIN; PEMOLINE; PEMOLINE MAGNESIUM; PHENYTOIN; PROSTAGLANDIN E1; SERTRALINE; SILDENAFIL; TADALAFIL; TIZANIDINE; TOLTERODINE; TOPIRAMATE; UNINDEXED DRUG; VARDENAFIL; VENLAFAXINE;

BLADDER DYSFUNCTION; CLINICAL FEATURE; COGNITION; DEPRESSION; DRUG EFFICACY; DYSESTHESIA; ERECTILE DYSFUNCTION; EXERCISE; FATIGUE; FEVER; HUMAN; INFLAMMATION; LIVER DISEASE; MULTIPLE SCLEROSIS; MUSCLE WEAKNESS; PAIN; PANIC; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SIDE EFFECT; SPASTICITY; SWALLOWING; TREMOR; TRIGEMINUS NEURALGIA; XEROSTOMIA;

FATIGUE; HUMANS; MULTIPLE SCLEROSIS; NERVOUS SYSTEM DISEASES; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SPASM; URINATION DISORDERS;

EID: 12344254795     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ncl.2004.09.001     Document Type: Review

References (29)

1. J.D. Fisk, A. Pontefract, and P.G. Ritvo The impact of fatigue on patients with MS Can J Neurol Sci 21 1994 9 14
2. H.P. Attarian, K.M. Brown, and S.P. Duntley The relationship of sleep disturbances and fatigue in multiple sclerosis Arch Neurol 61 2004 525 528
3. L.B. Krupp, L.A. Alvarez, and N.B. LaRocca Fatigue in multiple sclerosis Arch Neurol 45 1988 435 451
4. T.J. Murray Amantidine therapy for fatigue in multiple sclerosis Can J Neurol Sci 12 1985 251 254
5. B. Bass, B.G. Weinshenker, and M. Penman A double-blind, placebo-controlled trial to compare the efficacy of cylert (pemoline) and placebo in the control of fatigue in multiple sclerosis Neurology 40 Suppl 1 1990 261
6. K.W. Rammohan, J.H. Rosenberg, and D.J. Lynn Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two center phase 2 study J Neurol Neurosurg Psychiatry 72 2002 179 183
7. R.T. Schapiro The management of MS symptoms 2003 Demos Medical Publishing New York
8. R.R. Young Treatment of spastic paresis N Engl J Med 320 1985 1953 1955
9. M.C. Hokystrater, R.J.D. van der Ploeg, and W. van der Burg Treatment of spasticity in multiple sclerosis patients Acta Neurol Scand 77 1988 224 230
10. J. Borg-Stein, Z. Fine, and R.J. Mille Botulinum toxin for the treatment of spasticity in multiple sclerosis Am J Phys Med Rehabil 72 1993 364 368
11. J. Killestein, B.M. Uitdehaag, and C.H. Polman Cannabinoids in multiple sclerosis: do they have a therapeutic role? Drugs 64 2004 1 11
12. S. Beard, A. Hunn, and J. Wight Treatments for spasticity and pain in multiple sclerosis: a systematic review Health Technol Assess 7 2003 iii ix-x, 1-111
13. R.D. Penn, S.M. Savoy, and D. Corcos Intrathecal baclofen for severe spinal spasticity N Engl J Med 320 1989 1517 1521
14. DMKG Study Group Misoprostol in the treatment of trigeminal neuralgia associated with multiple sclerosis J Neurol 250 2003 542 545
15. P. Warnell The pain experience of a multiple sclerosis population: a descriptive study Axone 13 1991 26 28
16. A. Giannantoni, G. Scivoletto, and S.M. DiStasi Lower urinary tract dysfunction and disability status in multiple sclerosis Arch Phys Med Rehabil 80 1999 437 441
17. G. Valiquette, J. Herbert, and P. Maede-D'Alisera Desmopressin in the management of nocturia in patients with multiple sclerosis, a double blind crossover trial Arch Neurol 53 1996 1270 1275
18. K. Billups, L. Berman, and J. Berman A new non-pharmacological vacuum therapy for female sexual dysfunction J Sex Marital Ther 27 2001
19. M.A. Ron, and S.J. Logsdail Psychiatric morbidity in multiple sclerosis: a clinical and MRI study Psychol Med 19 1989 887 895
20. S.B. Patten, C.A. Beck, and J.V. Williams Major depression in multiple sclerosis: a population-based perspective Neurology 61 2003 1524 1527
21. A.D. Sadovnik, R.A. Remick, and J. Allen Depression and multiple sclerosis Neurology 46 1996 628 632
22. R.B. Schiffer, and H.M. Babigian Behavioral disorders in multiple sclerosis, temporal lobe epilepsy, and amyotrophic lateral sclerosis, an epidemiologic study Arch Neurol 41 1984 1067 1069
23. J.H. Petajan, and A.T. White Recommendations for physical activity in multiple sclerosis Sports Med 27 1999 179 191
24. S. Rao, G.T. Leo, and L. Bernardin Cognitive dysfunction in multiple sclerosis I. Frequency, pattern and predictors Neurology 41 1991 685 691
25. B. Bagert, P. Camplair, and D. Bourdette Cognitive dysfunction in multiple sclerosis: natural history, pathophysiology and management CNS Drugs 16 2002 445 455
26. J.M. Peyser, K.R. Edmals, and C.M. Poser Cognitive function in patients with multiple sclerosis Arch Neurol 47 1980 94 97
27. C.H. Polman, F.W. Bertelsmann, and A.C. van Loenen 4-Aminopyridine in the treatment of patients with multiple sclerosis. Long-term efficacy and safety Arch Neurol 51 1994 292 296
28. K. Syndulko, A. Woldanski, and R.W. Baumhefner Preliminary evaluation of lowering tympanic temperature for the symptomatic treatment of multiple sclerosis J Neurol Rehab 9 1995 205 214
29. K.B. Svendsen, T.S. Jensen, and K. Overvad Pain in patients with multiple sclerosis: a population-based study Arch Neurol 60 2003 1089 1094